本页面由Tiger Trade Technology Pte. Ltd.提供服务

Lyra Therapeutics, Inc.

0.6600
0.0000
成交量:5,596.00
成交额:3,693.36
市值:117.14万
市盈率:-0.03
高:0.6600
开:0.6600
低:0.6600
收:0.6600
52周最高:37.50
52周最低:0.3100
股本:177.49万
流通股本:132.37万
量比:0.53
换手率:0.42%
股息:- -
股息率:- -
每股收益(TTM):-22.9324
每股收益(LYR):-71.7474
净资产收益率:-6594.98%
总资产收益率:-36.06%
市净率:-0.11
市盈率(LYR):-0.01

数据加载中...

2026/04/10

重要事件披露

Form 8-K - Current report
2026/03/31

年度报告

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
2026/03/26

员工持股计划

Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments
2026/03/26

员工持股计划

Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments
2026/03/26

员工持股计划

Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments
2026/03/26

员工持股计划

Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments
2026/03/26

员工持股计划

Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments
2026/03/17

重要事件披露

Form 8-K - Current report
2026/02/27

重要事件披露

Form 8-K - Current report
2026/02/06

重要事件披露

Form 8-K - Current report
2026/01/27

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/01/12

重要事件披露

Form 8-K - Current report
2026/01/06

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/11/13

季度报告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2025/11/13

重要事件披露

Form 8-K - Current report
2025/10/14

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/09/04

重要事件披露

Form 8-K - Current report
2025/08/22

重要事件披露

Form 8-K - Current report
2025/08/12

重要事件披露

Form 8-K - Current report
2025/08/12

季度报告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]